Drug · DIN 00451207
TIMOPTIC
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 2, 2020; first marketed December 31, 1979.
- Drug Identification Number (DIN)
- 00451207
- Company (DIN owner)
- Elvium Life SciencesToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Timolol S01ED01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TIMOLOL (TIMOLOL MALEATE) | 0.5 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 20, 2020: NOC 24083New Drug Submission (NDS) · Administrative: Change in Product Ownership
- October 28, 2016: NOC 18658New Drug Submission (NDS) · Transfer of drug identification numbers
- June 17, 2005: NOC 7100New Drug Submission (NDS) · Manufacturer name change
Other DINs named TIMOPTIC
- DIN 00451193 · Cancelled Post Market